头颈癌共病与生存的关联:Head and Neck 5000研究结果
该研究基于英国多中心队列Head and Neck 5000中口腔癌(n=668)、口咽癌(n=1074)和喉癌(n=530)患者数据,逐步校正年龄、性别、婚姻状况、收入、教育、分期、饮酒和吸烟后分析生存。结果显示基线共病程度越高,总生存越差,结论提示共病是头颈癌总生存的独立预后因素,应在评估和治疗计划中加以考虑。
要点
- 基线轻度共病者总生存低于无共病者(HR=1.4,95%CI=1.1,1.7)。
- 基线中度共病者总生存低于无共病者(HR=1.7,95%CI=1.3,2.2)。
核心结论
- 研究结果表明共病是头颈癌总生存的独立预后因素。
- 作者认为在头颈癌患者的评估和治疗计划中应考虑共病情况。
研究设计与样本
- 研究为英国多中心队列研究,数据来自Head and Neck 5000参与者。
- 分析纳入口腔癌(n=668)、口咽癌(n=1074)和喉癌(n=530)患者。
- 生存分析逐步校正年龄、性别、婚姻状况、收入、教育、分期、饮酒和吸烟。
主要发现
- 校正人口学、临床和行为混杂因素后,基线共病程度越高总生存越差。
- 轻度共病者较无共病者总生存降低(HR=1.4,95%CI=1.1,1.7)。
- 中度共病者较无共病者总生存降低(HR=1.7,95%CI=1.3,2.2)。
关键数值与推荐
- 轻度共病HR=1.4,95%CI=1.1,1.7。
- 中度共病HR=1.7,95%CI=1.3,2.2。
- 趋势检验P<.001。
临床怎么用
- 作者认为在头颈癌患者的评估和治疗计划中应考虑共病情况。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with head and neck cancer have higher comorbidity levels but it remains unclear if pretreatment comorbidity is an independent prognosticator in head and neck cancer. METHODS: Survival analyses were performed using data from participants in a UK multicentre cohort study with cancers of the oral cavity (n = 668), oropharynx (n = 1074), and larynx (n = 530). Survival analyses were incrementally adjusted for age, sex, marital status, income, education, stage, alcohol, and smoking. RESULTS: After adjusting for demographic, clinical, and behavioral confounders, higher baseline comorbidity was associated with reduced overall survival (mild comorbidity HR = 1.4, 95% CI = 1.1, 1.7; moderate comorbidity HR = 1.7, 95% CI = 1.3, 2.2; severe comorbidity HR = 2.8, 95% CI = 1.9, 4.; P-trend<.001). CONCLUSIONS: Our findings suggest that comorbidity is an independent prognosticator for overall survival in head and neck cancer. Comorbid illnesses should be considered in the assessment and treatment planning of people with head and neck cancer.
引用
- Schimansky S, Lang S, Beynon R, et al. Association between comorbidity and survival in head and neck cancer: Results from Head and Neck 5000. Head Neck. 2018. PMID: 30549147. doi:10.1002/hed.25543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。